Anti-McHV-1 UDG Polyclonal Antibody from ProteoGenix; catalogue ARO-A22396; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-McHV-1 UDG Polyclonal Antibody is a highly efficient and specific tool for detecting and studying the McHV-1 virus. This antibody is produced through the use of advanced biotechnology techniques and has been rigorously tested for its quality and efficacy.
The Anti-McHV-1 UDG Polyclonal Antibody targets the Uracil-DNA glycosylase (UDG) protein of the McHV-1 virus. UDG is an essential enzyme for the replication of this virus, making it a crucial target for detection and research.
This antibody is primarily used for the detection and quantification of McHV-1 virus in biological samples. It is also useful for studying the viral replication process and understanding the mechanisms of McHV-1 infection.
The Anti-McHV-1 UDG Polyclonal Antibody has been successfully used in various experimental settings, including Western blotting, immunofluorescence, and immunohistochemistry. It has been proven to provide highly specific and sensitive results, making it a valuable tool for researchers studying McHV-1.
This antibody is specifically designed for researchers targeting the McHV-1 virus. Its high specificity and sensitivity make it a valuable tool for detecting and studying this virus in various biological samples.
Structure:
To ensure the best results, we recommend using the Anti-McHV-1 UDG Polyclonal Antibody in Western blotting, immunofluorescence, or immunohistochemistry experiments. Its superior performance and ease of use make it a top choice for researchers studying the McHV-1 virus.
In conclusion, the Anti-McHV-1 UDG Polyclonal Antibody is a highly efficient and specific tool for detecting and studying the McHV-1 virus. With its advanced biotechnology and proven efficacy, it is the ideal choice for researchers targeting this virus. Order now and take your McHV-1 research to the next level!
ProteoGenix catalogue number ARO-A22396. For research use only.
Target: uracil-DNA glycosylase, UL2; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| uracil-DNA glycosylase, UL2 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
